Antisense oligonucleotides
Antisense Oligonucleotides Modulating Activation of a Nonsense-Mediated RNA Decay Switch Exon in the ATM Gene
9
Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.
15
Dynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides.
14
RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.
25
Antisense Oligonucleotide technologies for neuronal cell regeneration after spinal injury
55
Papel da PI3K8 no controle da contratilidade vascular no Diabetes Mellitus I: estudo funcional e eletrofisiológico
5
Somatic gene therapy for hypertension
7
A Cytoplasmic New Catalytic Subunit of Calcineurin in Trypanosoma cruzi and Its Molecular and Functional Characterization
15
IL-1ß and BMPs - Interactive players of cartilage matrix degradation and regeneration
8
Quím. Nova vol.34 número9
4
To nick or not to nick: comparison of I-SceI single- and double-strand break-induced recombination in yeast and human cells.
15
Delivery of miRNA-targeted oligonucleotides in the rat striatum by magnetofection with Neuromag®
11
Poly-thymidine oligonucleotides mediate activation of murine glial cells primarily through TLR7, not TLR8.
11
Exonization of an Intronic LINE-1 Element Causing Becker Muscular Dystrophy as a Novel Mutational Mechanism in Dystrophin Gene
9
J. bras. pneumol. vol.32 número3 en a10v32n3
7
A spontaneous dominant-negative mutation within a 35S::AtMYB90 transgene inhibits flower pigment production in tobacco.
12
Membrane-enriched proteome changes and prion protein expression during neural differentiation and in neuroblastoma cells
13
BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY
16
Antisense mRNA for NPY-Y1 receptor in the medial preoptic area increases prolactin secretion
5
Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy
9